Role of marketing in early clinical development

Pharmaceutical News

Volumn 9, Issue 2, 2002, Pages 95-101

  Viray, Rico E ^a   Miller, Susan ^a  

^a CementWorks   (United States)

Author keywords

Competition; Globalization; Marketing; Phase H

Indexed keywords

ALOSETRON; AMLODIPINE; AMLODIPINE BESYLATE; ASTEMIZOLE; CALCIUM ANTAGONIST; CAPTOPRIL; CELECOXIB; CIMETIDINE; DIDANOSINE; ENALAPRIL MALEATE; FLUCONAZOLE; FLUOXETINE; INVERASE; ITRACONAZOLE; METOPROLOL TARTRATE; MEVINOLIN; NIFEDIPINE; PRAVASTATIN; PROPRANOLOL; RANITIDINE; RECOMBINANT BLOOD CLOTTING FACTOR 8; RITONAVIR; ROFECOXIB; SERTRALINE; SILDENAFIL; TERFENADINE; ZIDOVUDINE;

ARTHRITIS; CLINICAL TRIAL; COMMERCIAL PHENOMENA; DEVELOPMENT; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; ERECTILE DYSFUNCTION; HUMAN; IRRITABLE COLON; RESEARCH; REVIEW;

EID: 0036526183     PISSN: 1071894X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Bogan, C. & Wang, D. (2000). Launching a blockbuster: The making and marketing of megabrands. Pharm. Exec., 20(8), 96-104.
2. Kaitin, K.I. (2000). Impact of the Prescription Drug User Fee Act of 1992 on the Speed of New Drug Development. FDA public hearing on PDUFA; September 15, Washington, DC.
3. Outlook 2002. Tufts Center for the Study of Drug Development cost study [Electronic version]. Retrieved February 2, 2002 from the Tufts Center for the Study of Drug Development web site: http://www.tufts.edu/med/csdd
4. Grabowski, H.G. & Vernon, J.M. (1994). Returns to R&D on new drug introductions in the 1980s. J. Health Econ., 13, 383-406.
5. DiMasi, J.A. (2001). New drug development in US 1963-1999. Clin. Pharmacol. Ther., 5(69), S286-91.
6. Redmond, C. (2001). Branding: Change & challenge. Pharm. Exec., 21(9), 58-66.
7. 2001 Industry Profile. Pharmaceutical Research and Manufacturers of America. PhRMA, Washington (DC).
8. 'Power Peddling' Drug Lifecycles (2002). IMS Health web site: http://www.inpharm.com/intelligence/ims041101.html
9. Gladwell, M. (2000). The Tipping Point. Little, Brown and Company, New York.